Journal of Antimicrobial Chemotherapy logo Oxford University Press logo

The Journal of Antimicrobial Chemotherapy is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

Publisher: Oxford University Press

Volume 44, Number 2, August 1999
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Leading articles. Penicillin-resistant Streptococcus pneumoniae: selection by both β-lactam and non-β-lactam antibiotics
pp. 141-144(4)
Author: Goldstein, FW

Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma
pp. 145-148(4)
Author: Cook, PJ

Editorial. Over-the-counter antibiotics
pp. 149-150(2)
Author: Wood, MJ

The 1998 Garrod Lecture. Current and future antifungal therapy: new targets for antifungal agents
pp. 151-162(12)
Author: Andriole, VT

Working party report. Self-medication of antibacterials without prescription (also called 'over-the-counter' use). A report of a working party of the British Society for Antimicrobial Chemotherapy
pp. 163-177(15)
Authors: Reeves, DS; Finch, RG; Bax, RP; Davey, PG; Po, ALW; Lingam, G; Mann, SG; Pringle, MAL

Original articles. In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic
pp. 179-192(14)
Authors: Candiani, G; Abbondi, M; Borgonovi, M; Romanò, G; Parenti, F

Intracellular activity of trovafloxacin against Staphylococcus aureus
pp. 193-199(7)
Authors: van den Broek, PJ; Koot, TGA; an Strijen, E; Mattie, H

Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae
pp. 201-207(7)
Author: Mitsuyama, J

Inhibition of potassium transport and growth of mycobacteria exposed to clofazimine and B669 is associated with a calcium-independent increase in microbial phospholipase A2 activity
pp. 209-216(8)
Authors: Steel, HC; Matlola, NM; Anderson, R

Involvement of calcium inhibitable binding to the cell wall in the fungicidal activity of CAN-296
pp. 217-222(6)
Authors: Ben-Josef, AM; Manavathu, EK; Platt, D; Sobel, JD

In-vitro activity of dicationic aromatic compounds and fluconazole against Cryptococcus neoformans and Candida spp.
pp. 223-228(6)
Authors: Del Poeta, M; Bixel, AS; Barchiesi, F; Tidwell, RR; Boykin, D; Scalise, G; Perfect, JR

The antibacterial efficacy of trovafloxacin against an experimental infection with Listeria monocytogenes in hydrocortisone-treated mice
pp. 229-234(6)
Author: van Ogtrop, ML

Population pharmacokinetics of amikacin in patients with haematological malignancies
pp. 235-242(8)
Authors: Romano, S; de Gatta, MMF; Calvo, MV; Caballero, D; Dominguez-Gil, A; Lanao, JM

Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India
pp. 243-250(8)
Authors: Butler, T; Sridhar, CB; Dagac, MK; Pathak, K; Pandit, RB; Khakhria, R; Potkar, CN; Zelasky, MT; Johnson, RB

The efficacy and safety of quinupristin/dalfopristin for the treatment of infections cause by vancomycin-resistant Enterococcus faecium
pp. 251-261(11)
Authors: Moellering, RC; Linden, PK; Reinhardt, J; Blumberg, EA; Bompart, f; Talbot, GH; Emergency-Use Study Group, Synercid

Treatment of hospitalized patients with complicated Gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin
pp. 263-273(11)
Authors: Nichols, RL; Graham, DR; Barriere, SL; Rodgers, A; Wilson, SE; Zervos, M; Dunn, DL; Kreter, B; Skin, Synercid; Structure Infection Group, Skin

Brief reports. Endothelial cell compatibility of clindamycin, gentamicin, ceftriaxone and teicoplanin in Bier's arterial arrest
pp. 275-277(3)
Authors: Vorbach, H; Robibaro, B; Armbruster, C; Atteneder, M; Reiter, M; Hlousek, M; Schaumann, R; Georgopoulos, A

Bactericidal action of oral ampicillin/sulbactam against Mycobacterium leprae
pp. 279-281(3)
Authors: Randhawa, B; Harris, EB; Prabhakaran, K

In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
pp. 283-286(4)
Authors: Ramos, G; Cuenca-Estrella, M; Monzón, A; Rodríguez-Tudela, JL

Ceftriaxone versus vancomycin prophylaxis in cardiovascular surgery
pp. 287-290(4)
Authors: Salminen, U-S; Viljanen, TUT; Valtonen, VV; Ikonen, TEH; Sahlman, AE; Harjula, ALJ

Correspondence. Personalized antifungal susceptibility testing
pp. 291-291(1)
Author: Shah, PM

Book reviews
pp. 303-305(3)
Author: Various,

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A